DJIA 17,959.44 154.64 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

92.80 -1.04 (-1.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $92.80 -1.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $93.34
Previous Close $93.84
Daily Range $91.20 - $93.89
52-Week Range $55.04 - $96.36
Market Cap $13.7B
P/E Ratio -106.64
Dividend (Yield) $0.00 (0.0%)
Volume 958,427
Average Daily Volume 1,237,239
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015

4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog

With Mid-2015 NDA Submission, Sarepta Can Rise

UPDATE: UBS Securities Reiterates On BioMarin Pharmaceutical On Path To Long-Term Upside

Biomarin Pharmaceutical (BMRN) Hits New Lifetime High

FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of

FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of MPS IIIB

5 Biotech Stocks to Buy for 2015

These five biotech stocks may have what it takes to reward investors next year.

BioMarin Will Report Breadth of Innovative Development Pipeline at Analyst, Investor Day

3 Biotech Companies That Are Making Incredibly Smart Moves

Here's how Gilead Sciences, BioMarin, and Amgen are planning ahead to maintain their market leadership.

See More BMRN News...

BMRN's Top Competitors

BMRN $92.80 (-1.11%)
Current stock: BMRN
AMGN $164.53 (-3.31%)
Current stock: AMGN
CELG $113.50 (-3.14%)
Current stock: CELG
BIIB $352.29 (-2.32%)
Current stock: BIIB